Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus

CompletedOBSERVATIONAL
Enrollment

255

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2011

Conditions
Barrett's Esophagus
Trial Locations (6)

48109

University of Michigan, Ann Arbor

Unknown

Dana Farber Cancer Institute, Boston

Columbia University, New York

Mt. Sinai School of Medicine, New York

MD Anderson Cancer Center, Houston

St. Michael's Hospital, Toronto

All Listed Sponsors
collaborator

Early Detection Research Network

NETWORK

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Unity Health Toronto

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

Columbia University

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan

OTHER

NCT00844077 - Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus | Biotech Hunter | Biotech Hunter